What is Medorion?
Founded in 2017 and headquartered in Tel Aviv, Medorion operates at the intersection of data science and behavioral economics. The company provides an AI-powered platform that meticulously analyzes claims data alongside social determinants of health. By identifying the psychological, environmental, and economic barriers that influence individual health decisions, Medorion enables healthcare providers and payers to optimize delivery models. This analytical capability not only improves clinical outcomes but also drives significant financial efficiencies, positioning the firm as a vital asset for organizations navigating the complexities of modern value-based care.
How much funding has Medorion raised?
Medorion has raised a total of $6M across 1 funding round:
Unspecified
$6M
Unspecified (2021): $6M with participation from TAU Ventures, iAngels, and 10D
Key Investors in Medorion
TAU Ventures
A venture capital firm affiliated with Tel Aviv University, focusing on early-stage investments in deep-tech and innovative software solutions.
iAngels
A prominent investment platform that provides access to high-growth technology startups, often focusing on Israeli innovation and scalable digital enterprises.
10D
A venture capital firm specializing in early-stage investments, with a strong focus on supporting transformative technologies and data-centric business models.
What's next for Medorion?
With this major enterprise-level funding, Medorion is well-positioned to scale its operations and deepen its technological moat. The company is expected to focus on expanding its predictive modeling capabilities and broadening its footprint within the global healthcare market. As the industry increasingly prioritizes preventative care and data-driven decision-making, Medorion's strategic roadmap likely includes enhancing its platform's interoperability and accelerating the adoption of its insights-driven solutions among large-scale health insurers and provider networks. This growth trajectory suggests a sustained commitment to transforming how health systems interpret and act upon patient behavior data.
See full Medorion company page
